Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.
Dr Ola Engkvist, AstraZeneca, explains how deep learning architectures improve chemical reaction prediction.Watch Now
Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.
Northwestern University and Washington University School of Medicine researchers have developed the first example of a bioelectronic medicine: an implantable, biodegradable wireless device that speeds nerve regeneration and improves healing of a damaged nerve. Their device delivered pulses of electricity to damaged nerves in rats after a surgical repair process, accelerating the regrowth of nerves and enhancing the recovery of muscle strength and control. The device is the size of a dime and the thickness of a sheet of paper and dissolves in the body after about two weeks.